Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
09 nov. 2023 08h15 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
China Pharmaceutical Market Landscape and Drugs Pipeline Analysis Report 2023: Business Overview, Clinical Pipeline Insight, Preclinical, Phase-I, Phase-II, Phase-III, Preregistration
06 nov. 2023 05h03 HE
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Pharmaceutical Companies and Drugs Pipeline Insight 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. Chinese...
Global Inhalable Drugs Industry Trends and Competitive Landscape 2023-2027: North America Leads, Asia-Pacific Shows Promise
01 nov. 2023 08h23 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Inhalable Drugs Industry Trends and Competitive Landscape 2023-2027" report has been added to ResearchAndMarkets.com's offering.The global...
Global Oncolytic Virus Therapy Market Trends and Opportunities 2023-2027: Insights for HSV-based Oncolytic Virus, Adenovirus-based Oncolytic Virus, Reovirus, Poxviruses, NDV, and Other Therapy Types
01 nov. 2023 08h08 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market 2023" report has been added to ResearchAndMarkets.com's offering. The global oncolytic virus therapy market is...
Rising Incidence of Pediatric Diseases and Advances in Research Drive Pediatric Drugs Market Growth
25 oct. 2023 09h08 HE
|
Research and Markets
Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Drugs Market by Type, by Route of Administration, Distribution Channel, and by Region - Global Forecast to 2023-2033" report has been added...
Advancements in Healthcare and Targeted Therapies Propel Multiple Myeloma Drugs Market Towards $29.6 Billion by 2028
25 oct. 2023 08h23 HE
|
Research and Markets
Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Key Segments of the Medication Adherence Market: A Comprehensive Analysis of Patient-Provider Medication Management
17 oct. 2023 06h43 HE
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Medication Adherence Devices - A Global and Regional Analysis: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's...
Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester
16 oct. 2023 05h30 HE
|
Research Nester
New York, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The global somatostatin analogs market size is slated to expand at ~6% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 10...
Processa Pharmaceuticals to Present at the ThinkEquity Conference
13 oct. 2023 13h08 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Panavance to Present at the BIO Investor Forum
05 oct. 2023 07h07 HE
|
Panavance Therapeutics Inc.
BERWYN, PA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Panavance Therapeutics Inc. (“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of misetionamide...